These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7600545)

  • 21. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of Ginkgo biloba against rat liver carcinogenesis.
    Dias MC; Rodrigues MA; Reimberg MC; Barbisan LF
    Chem Biol Interact; 2008 May; 173(1):32-42. PubMed ID: 18367157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
    Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
    Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
    Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
    Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.
    Everitt JI; Walker CL; Goldsworthy TW; Wolf DC
    Mol Carcinog; 1997 Jul; 19(3):213-9. PubMed ID: 9254888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target cell populations in virus-associated hepatocarcinogenesis.
    Thorgeirsson SS
    Princess Takamatsu Symp; 1995; 25():163-70. PubMed ID: 8875621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms.
    Kaufmann WK; Zhang Y; Kaufman DG
    Carcinogenesis; 1992 Aug; 13(8):1481-3. PubMed ID: 1499100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models of hepatocarcinogenesis in the rat--contrasts and comparisons.
    Goldsworthy TL; Hanigan MH; Pitot HC
    Crit Rev Toxicol; 1986; 17(1):61-89. PubMed ID: 3527567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental induction of hepatocellular carcinoma as a paradigm for carcinogenesis.
    Farber E
    Clin Physiol Biochem; 1987; 5(3-4):152-9. PubMed ID: 3621796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage-specific gene expression during hepatocarcinogenesis in the rat.
    Pitot HC
    J Cancer Res Clin Oncol; 1996; 122(5):257-65. PubMed ID: 8609148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adventures in hepatocarcinogenesis.
    Pitot HC
    Annu Rev Pathol; 2007; 2():1-29. PubMed ID: 18039091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental modifiers in carcinogenesis.
    Pitot HC
    IARC Sci Publ; 1982; (39):165-76. PubMed ID: 6295932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression.
    Hikita H; Vaughan J; Babcock K; Pitot HC
    Toxicol Sci; 1999 Dec; 52(2 Suppl):17-23. PubMed ID: 10630586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.
    Dragan YP; Laufer C; Koleske AJ; Drinkwater N; Pitot HC
    Jpn J Cancer Res; 1993 Feb; 84(2):175-83. PubMed ID: 8463134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunomorphological analysis of the level of differentiation of hepatocellular tumors in rats].
    Gel'shteĭn VI; Chipysheva TA; Bannikov GA
    Arkh Patol; 1984; 46(9):75-81. PubMed ID: 6210073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution of antigneic markers of differentiation--ligandin and alpha-fetoprotein--in the early stages of chemical carcinogenesis in rat liver].
    Bannikov GA; Gel'shteĭn VI; Chipysheva TA
    Vestn Akad Med Nauk SSSR; 1977; (3):39-41. PubMed ID: 70124
    [No Abstract]   [Full Text] [Related]  

  • 39. Neoplastic progression in experimental hepatocarcinogenesis.
    Scherer E
    Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.
    Pitot HC; Hikita H; Dragan Y; Sargent L; Haas M
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():153-60. PubMed ID: 10807417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.